The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol.

BACKGROUND & AIMS The optimal management of high-grade dysplasia in Barrett's esophagus remains controversial. A biopsy protocol consisting of 4 quadrant jumbo biopsies (every 1 cm) with biopsies of mucosal abnormalities (the Seattle protocol) is considered to be the optimal method for detecting early cancers in patients with high-grade dysplasia, although it has never been validated. This study aimed to determine the frequency of unsuspected carcinoma at esophagectomy in Barrett's esophagus patients with high-grade dysplasia who underwent the Seattle protocol and to compare the findings with those of a less rigorous biopsy protocol. METHODS Thirty-three patients with high-grade dysplasia underwent esophagectomy. None had obvious mass lesions at preoperative endoscopy. Patients were divided into group 1 (preoperative surveillance biopsies according to Seattle protocol) and group 2 (4 quadrant biopsies every 2 cm). Preoperative and postoperative diagnoses were confirmed by 2 expert gastrointestinal pathologists. RESULTS Unsuspected intramucosal cancer was found in 8 of 20 (40%) patients in group 1 versus 4 of 13 (30%) in group 2 (P = .6). Preoperative mucosal nodularity was observed in 4 of 8 (50%) postoperative intramucosal cancers from group 1 versus 3 of 4 (75%) from group 2. Multifocal high-grade dysplasia was seen preoperatively in 7 of 8 (87.5%) postoperative intramucosal cancers in group 1 versus 2 of 4 (50%) in group 2. No patient had submucosal cancer or lymph node metastases at surgery. CONCLUSIONS Intense preoperative biopsy sampling by the Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. This calls into question the concept that extensive sampling with the Seattle protocol consistently detects early cancers arising in Barrett's esophagus patients with high-grade dysplasia.

[1]  A. Ruol,et al.  Oesophageal resection for high‐grade dysplasia in Barrett's oesophagus , 2000, The British journal of surgery.

[2]  C. Gutschow,et al.  Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view. , 2003, Journal of the American College of Surgeons.

[3]  V. Konda,et al.  Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  D. Faigel,et al.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.

[5]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[6]  Therese A. Stukel,et al.  Surgeon volume and operative mortality in the United States , 2004 .

[7]  P. Pairolero,et al.  Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? , 1992, The Annals of thoracic surgery.

[8]  B. Edil,et al.  Surgical treatment of esophageal high-grade dysplasia. , 2005, The Annals of thoracic surgery.

[9]  C. Yeo,et al.  Barrett’s esophagus with high grade dysplasia: Surgical results and long-term outcome— An update , 2003, Journal of Gastrointestinal Surgery.

[10]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[11]  J. Goldblum,et al.  Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. , 1999, Gastrointestinal endoscopy.

[12]  Prateek Sharma,et al.  Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus? , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  R. Heitmiller,et al.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.

[14]  C. Pellegrini,et al.  Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for barrett’s esophagus , 2006, Journal of Gastrointestinal Surgery.

[15]  Verna C. Gibbs,et al.  Barrett’s esophagus: A surgical disease , 1999, Journal of Gastrointestinal Surgery.

[16]  P. Pairolero,et al.  High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. , 2002, The Annals of thoracic surgery.

[17]  P. Fockens,et al.  Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.

[18]  T. Rice,et al.  Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.

[19]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[20]  Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). , 2005 .

[21]  T. Rice.  PRO: Esophagectomy is Indicated for High-Grade Dysplasia in Barrett's Esophagus , 2006, The American Journal of Gastroenterology.

[22]  J. Goldblum,et al.  Can extent of high grade dysplasia in Barrett’s oesophagus predict the presence of adenocarcinoma at oesophagectomy? , 2003, Gut.

[23]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[24]  H. W. Boyce,et al.  Barrett esophagus: endoscopic findings and what to biopsy. , 2003, Journal of clinical gastroenterology.

[25]  W H Henricks,et al.  Observer variation in the diagnosis of superficial oesophageal adenocarcinoma , 2002, Gut.

[26]  J. Goldblum,et al.  Superficial adenocarcinoma of the esophagus. , 2001, The Journal of thoracic and cardiovascular surgery.

[27]  L. Gossner,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[28]  G. Portale,et al.  Predictive factors of coexisting cancer in Barrett’s high-grade dysplasia , 2006, Surgical Endoscopy And Other Interventional Techniques.

[29]  Kenneth K Wang,et al.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.

[30]  Kenneth J. Chang,et al.  213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial , 2008 .

[31]  K. Naunheim,et al.  Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. , 1997, The Journal of thoracic and cardiovascular surgery.

[32]  D. Low,et al.  Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. , 2006, Archives of surgery.

[33]  D. Low,et al.  Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. , 2008, Gastrointestinal endoscopy.

[34]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[35]  J H Peters,et al.  Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. , 1999, Annals of surgery.

[36]  Elizabeth R Tschanz,et al.  Do 40% of patients resected for barrett esophagus with high-grade dysplasia have unsuspected adenocarcinoma? , 2005, Archives of pathology & laboratory medicine.

[37]  Prateek Sharma,et al.  Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[38]  S. Merigliano,et al.  Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). , 1997, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[39]  Patricia L. Blount,et al.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.

[40]  J. Peters,et al.  Esophagectomy for High Grade Dysplasia is Safe, Curative, and Results in Good Alimentary Outcome , 2007, Journal of Gastrointestinal Surgery.

[41]  P. Blount,et al.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. , 2000 .

[42]  M. Bronner,et al.  Poor Interobserver Agreement in the Distinction of High-Grade Dysplasia and Adenocarcinoma in Pretreatment Barrett's Esophagus Biopsies , 2008, The American Journal of Gastroenterology.

[43]  R. Kozarek,et al.  Esophagectomy—It’s Not Just About Mortality Anymore: Standardized Perioperative Clinical Pathways Improve Outcomes in Patients with Esophageal Cancer , 2007, Journal of Gastrointestinal Surgery.

[44]  A. Bansal,et al.  The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[45]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[46]  M. Sprangers,et al.  Quality of life in long‐term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma , 2000, The British journal of surgery.

[47]  Dennis M. Riehle,et al.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.

[48]  N. Altorki,et al.  High-grade dysplasia in the columnar-lined esophagus. , 1991, American journal of surgery.

[49]  A. Cameron,et al.  Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. , 1997, The American journal of gastroenterology.

[50]  Kenneth K Wang,et al.  American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma. , 2005, Gastroenterology.

[51]  R. Romagnoli,et al.  Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. , 1997, American journal of surgery.

[52]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[53]  P. Fockens,et al.  Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.

[54]  Paul Fockens,et al.  Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[55]  J. Richardson,et al.  The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. , 1996, Annals of surgery.